Document Detail


Innovar treatment for Meniere's disease.
MedLine Citation:
PMID:  10320074     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Patients with intractable vertigo due to clinical Meniere's disease were offered treatment with Innovar, a neurolept analgesic. The patients were from a single clinical practice, had failed conventional dietary and medical treatment and were eligible on clinical grounds for endolymphatic sac surgery. After a follow-up of 2-8 years, 58% of patients had long-lasting relief of vertigo. Hearing was not affected. Risk factors for a favorable response were male gender, fluctuating hearing, and early stage of the disorder. Innovar is a safe, cost-effective second-line therapy for patients with Meniere's disease who have failed conventional first-line medical therapy.
Authors:
G A Gates
Related Documents :
19243624 - Co-morbidity and visual acuity are risk factors for health-related quality of life decl...
17159494 - Dynamic posturography findings predict balance status in vestibular schwannoma patients.
1535574 - Inflammatory and papulosquamous disorders of the skin and eye.
23703374 - Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for...
6958014 - Treatment of uncomplicated genital chlamydia trachomatis infections in males.
12829974 - Why patients do not comply with compression bandaging.
Publication Detail:
Type:  Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Acta oto-laryngologica     Volume:  119     ISSN:  0001-6489     ISO Abbreviation:  Acta Otolaryngol.     Publication Date:  1999 Mar 
Date Detail:
Created Date:  1999-06-30     Completed Date:  1999-06-30     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0370354     Medline TA:  Acta Otolaryngol     Country:  NORWAY    
Other Details:
Languages:  eng     Pagination:  189-93     Citation Subset:  IM    
Affiliation:
Department of Otolaryngology--Head and Neck Surgery, University of Washington School of Medicine, Seattle, USA. ggates@u.washington.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Aged
Analgesics / therapeutic use*
Droperidol / therapeutic use*
Female
Fentanyl / therapeutic use*
Follow-Up Studies
Humans
Male
Meniere Disease / drug therapy*
Middle Aged
Risk Factors
Time Factors
Treatment Outcome
Chemical
Reg. No./Substance:
0/Analgesics; 437-38-7/Fentanyl; 548-73-2/Droperidol; 8067-59-2/Innovar

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Acetylcholine-induced phosphorylation in isolated outer hair cells.
Next Document:  The endolymphatic sac, a potential endocrine gland?